ArticleInternational journal of hematology2024
Achievement of deep molecular response and treatment-free remission with asciminib treatment in CML.
Ryo Yoshimaru et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it